CJC-1295

CJC-1295 research peptide. Third-party Certificates of Analysis are published for tested products and batches. Fast UK dispatch. For laboratory research use only.

Product vial
CEDAR CJC-1295 LYOPHILISED POWDER FOR RESEARCH USE ONLY BATCH: EXP: STORAGE:2–8°C

Available sizes: 5mg | No DAC, 5mg | With DAC, 10mg | No DAC

A Growth Hormone Releasing Hormone Analogue Studied in Endocrine and Metabolic Signalling Research

CJC-1295 is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH) studied in laboratory research examining how the body regulates natural growth hormone production.

Researchers investigate CJC-1295 for its ability to interact with signalling pathways that stimulate the pituitary gland to release endogenous growth hormone. Because growth hormone plays a key role in tissue repair, metabolism, and cellular recovery processes, peptides that influence this pathway are widely studied in endocrine and metabolic research.

CJC-1295 is therefore frequently examined in laboratory models exploring growth hormone regulation, endocrine signalling pathways, and metabolic hormone coordination.

Why CJC-1295 Is Studied

  • Growth Hormone Signalling: CJC-1295 is commonly examined in research investigating stimulation of endogenous growth hormone release.

  • GHRH Receptor Interaction: Researchers study how the peptide interacts with receptors that regulate pituitary hormone secretion.

  • Endocrine Pathway Research: Laboratory models investigate how hypothalamic signalling peptides coordinate hormone release within the endocrine system.

  • Metabolic Regulation Models: Growth hormone signalling pathways are widely studied for their influence on metabolism, tissue repair, and cellular growth.

Scientific Research Context

Growth hormone secretion is regulated through signalling molecules released from the hypothalamus that activate receptors within the pituitary gland. CJC-1295 mimics the activity of natural GHRH, allowing researchers to examine how endocrine signals regulate hormone release and downstream metabolic pathways.

Because of this mechanism, CJC-1295 is widely used in laboratory environments investigating growth hormone signalling, endocrine communication, and metabolic hormone regulation.

Common Research Focus Areas

  • Growth hormone secretion studies

  • Hypothalamic–pituitary signalling research

  • Endocrine pathway regulation models

  • Metabolic hormone signalling research

Related Peptides

CJC-1295 belongs to a group of peptides studied for their interaction with growth hormone signalling pathways.

Researchers examining endocrine signalling models frequently explore compounds such as Ipamorelin, Sermorelin, and Tesamorelin.

Documentation and verification

Certificates of Analysis are published for tested products and batches. A certificate is a batch-specific record: it reports what was measured, by which method, on a stated date, against a batch identifier. It is evidence about the sample analysed at the time of analysis, and it is silent on attributes it does not list and on what has happened to the material since.

The batch number is the field that connects the document to a physical vial. Where the identifier on a vial does not appear on a certificate, the certificate does not describe that vial, however thorough the analysis behind it was. Batch records can be searched directly, and the guides below explain what each field establishes and what it does not.

Supplied for laboratory research use only. Not for human or veterinary use.